Oncosil Medical Ltd has released a press release.
OncoSil Receives $832k R&D Tax Incentive
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from OncoSil Medical
- OncoSil to Present at South-West Connect ASX Showcase
- Appendix 4E Announcement
- Investor Presentation
- Monthly Activities/Appendix 4C Cash Flow Report
- Patient treated in Spain proceeds to successful resection
Later from OncoSil Medical
- 2022 AGM CEO Presentation
- Distribution agreement signed for selected Chinese markets
- OncoSil achieves milestone of 10 patients treated in Spain
- Two key treatment centres treat first patients with OncoSil
- Half Yearly Report and Accounts
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical